Bonnie Appler, PA
Physician Assistant · Jacksonville, FLNPI 1871721266
Payments from drug & device makers
Across 550 payments — averaging $90.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$16K
- Esperion Therapeutics, Inc.$13K
- Ionis Pharmaceuticals, Inc.$6K
- Regeneron Healthcare Solutions, Inc.$4K
- Amgen$3K
- Pfizer$1K
- plus $7K from 31 others
What the payments were for
- Consulting fees$6,92814%
- Speaking & faculty fees$22,95346%
- Travel & lodging$5,12710%
- Food & beverage$14,77830%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 35 | $15,639 |
| Esperion Therapeutics, Inc. | 48 | $12,597 |
| Ionis Pharmaceuticals, Inc. | 16 | $6,485 |
| Regeneron Healthcare Solutions, Inc. | 28 | $4,055 |
| Amgen | 82 | $2,536 |
| Pfizer | 42 | $1,182 |
| Novartis | 44 | $1,012 |
| Boehringer Ingelheim | 31 | $994 |
| AstraZeneca | 33 | $985 |
| Alnylam Pharmaceuticals Inc. | 25 | $422 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $413 |
| E.r. Squibb & Sons, L.L.C. | 23 | $400 |
| Merck | 19 | $398 |
| Abiomed | 3 | $340 |
| Novo Nordisk | 11 | $304 |
| Scpharmaceuticals Inc. | 15 | $286 |
| Johnson & Johnson | 17 | $270 |
| Abbott | 10 | $212 |
| Boston Scientific | 4 | $179 |
| Kiniksa Pharmaceuticals International, PLC | 8 | $154 |
| Lexicon Pharmaceuticals, Inc. | 3 | $152 |
| Actelion Pharmaceuticals US, Inc. | 6 | $136 |
| Amarin Pharma, Inc. | 5 | $113 |
| Sanofi-aventis U.S. LLC | 5 | $86 |
| Philips North America LLC | 2 | $73 |
| Medtronic | 2 | $59 |
| Atricure, Inc. | 2 | $41 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Altathera Pharmaceuticals LLC | 1 | $34 |
| Bridgebio Pharma, Inc. | 1 | $30 |
| Sanofi | 1 | $28 |
| Regeneron | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Biotronik Inc. | 1 | $23 |
| United Therapeutics Corporation | 1 | $21 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$49,786 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 22 | $533,333 |
| EliquisApixaban | 151 | $147,863 |
| CamzyosMavacamten | 16 | $133,627 |
| EntrestoSacubitril/Valsartan | 127 | $127,959 |
| JardianceEmpagliflozin | 134 | $112,046 |
| Repatha SureclickEvolocumab | 84 | $72,204 |
| FarxigaDapagliflozin Propanediol | 69 | $66,141 |
| BrilintaTicagrelor | 32 | $20,271 |
| NexlizetBempedoic Acid/Ezetimibe | 20 | $11,593 |
| OzempicSemaglutide | 11 | $10,646 |
| VascepaIcosapent Ethyl | 17 | $10,386 |
| Rosuvastatin Calcium | 289 | $4,072 |
| Ezetimibe | 90 | $1,807 |
| Metoprolol Succinate | 140 | $1,749 |
| Atorvastatin Calcium | 169 | $1,698 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $1,182 | $681,196173 claims |
| E.r. Squibb & Sons, L.L.C.Camzyos | $400 | $133,62716 claims |
| NovartisEntresto | $1,012 | $127,959127 claims |
| Boehringer IngelheimJardiance | $994 | $112,046134 claims |
| AstraZenecaFarxiga, Brilinta | $985 | $86,412101 claims |
| Esperion Therapeutics, Inc.Nexlizet | $12,597 | $11,59320 claims |
| Novo NordiskOzempic | $304 | $10,64611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Jacksonville
- Elizabeth KeaneJacksonville$84K
- Layla McDanielJacksonville$74K
- Todd WurtzJacksonville$31K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.